Delivering innovative therapeutic options to improve patient health.

Founded in 2010, Althera develops innovative patient focused medicines to improve patient health.

Our first product Rosuvastatin/Ezetimibe (AL-320) is available to patients in more than 28 countries worldwide including all major European markets.

Althera’s second product Ezetimibe/Atorvastatin tablets (AL-310), is approved in both US and Europe, and is expected to be available to patients in 2022/23.

Health Care

Life Sciences

Therapeutics

Althera

Althera's headquarters in Morristown, NJ, United States

This department focuses on the research and development of formulation processes and products.

Formulation Development

The Research and Development team at Althera is dedicated to advancing innovative therapeutic solutions by conducting cutting-edge research and optimizing formulations for new medicines. This team collaborates to enhance the efficacy and safety of existing products while exploring new drug candidates that align with Althera’s mission to improve patient health. Through rigorous experimentation and data analysis, they aim to drive the development pipeline and bring groundbreaking therapies to market.

Research and Development

This department provides strategic direction and oversees the overall management and operations of the organization.

Executive Leadership

This department ensures product quality and compliance through rigorous testing and evaluation processes.

Quality Assurance

This department focuses on ensuring compliance with regulations and guidelines in the development and marketing of products.

Regulatory Affairs

This department oversees the execution and coordination of projects and operations across various sites.

People (4)

Jobs (0)

Other teams

Research and Development

Executive Leadership

Quality Assurance

Regulatory Affairs

Operations Management